Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (431-440 of 529) with videos related to

Pageof 53
Sort By:
Biorxiv : the Preprint Server for Biology|August 10, 2021
Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacityAkiko Koide, Tatyana Panchenko, Chan Wang, et al.
Clinical Pharmacology and Therapeutics|August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19Peter Chen, Gourab Datta, Ying Grace Li, et al.
The Journal of Infectious Diseases|July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteersT G Evans, M C Keefer, K J Weinhold, et al.
JAMA|March 6, 2015
Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestickLilin Lai, Richard Davey, Allison Beck, et al.
Journal of Virology|March 31, 2025
The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody responseAaron L Oom, Kesi K Wilson, Miilani Yonatan, et al.
Open Forum Infectious Diseases|November 2, 2020
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized PatientsRobert J Ulrich, Andrea B Troxel, Ellie Carmody, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2016
Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirusKaren K Wong, Richard T Davey, Angela L Hewlett, et al.
American Journal of Human Genetics|February 17, 2001
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing proteinM E Brunkow, J C Gardner, J Van Ness, et al.
Immunity|December 20, 2015
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular SignaturesHelder I Nakaya, Thomas Hagan, Sai S Duraisingham, et al.
Open Forum Infectious Diseases|January 31, 2019
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole BloodHana M El Sahly, Rodion Gorchakov, Lilin Lai, et al.
Pageof 53

Showing results (431-440 of 529) with videos related to

Sort By:
Pageof 53
Biorxiv : the Preprint Server for Biology|August 10, 2021
Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacityAkiko Koide, Tatyana Panchenko, Chan Wang, et al.
Clinical Pharmacology and Therapeutics|August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19Peter Chen, Gourab Datta, Ying Grace Li, et al.
The Journal of Infectious Diseases|July 9, 1999
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteersT G Evans, M C Keefer, K J Weinhold, et al.
JAMA|March 6, 2015
Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestickLilin Lai, Richard Davey, Allison Beck, et al.
Journal of Virology|March 31, 2025
The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody responseAaron L Oom, Kesi K Wilson, Miilani Yonatan, et al.
Open Forum Infectious Diseases|November 2, 2020
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized PatientsRobert J Ulrich, Andrea B Troxel, Ellie Carmody, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2016
Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirusKaren K Wong, Richard T Davey, Angela L Hewlett, et al.
American Journal of Human Genetics|February 17, 2001
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing proteinM E Brunkow, J C Gardner, J Van Ness, et al.
Immunity|December 20, 2015
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular SignaturesHelder I Nakaya, Thomas Hagan, Sai S Duraisingham, et al.
Open Forum Infectious Diseases|January 31, 2019
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole BloodHana M El Sahly, Rodion Gorchakov, Lilin Lai, et al.
Pageof 53